Wegovy and gallstones: why rapid weight loss raises the risk and the signs to know

Gallstones sit in the common band of Wegovy side effects, and the reason is mostly the weight loss itself rather than the molecule. Any method that takes weight off quickly raises gallstone risk, and Wegovy takes weight off quickly. Most gallstones never cause symptoms. When they do, the pain is distinctive, and it can also be the trigger for pancreatitis, which is why this guide sits alongside that one.

Gallstones: commonRaised bilirubin: uncommonChecked 20 October 2026Author: Nick Johnson

Key facts

Gallstones are a common Wegovy side effect: up to 1 in 10 people. In the weight management trials they were reported in roughly 1.6% of people on semaglutide against 0.7% on placebo; gallbladder inflammation (cholecystitis) in roughly 0.6% against 0.2%.
The main driver is rapid weight loss, which changes the balance of cholesterol and bile in the gallbladder. The faster the loss, the higher the risk.
Most gallstones cause no symptoms and are never found.
The classic symptom is severe pain under the right ribs or in the upper stomach, often after a fatty meal, lasting one to five hours.
Gallstone pain with fever, shivering, yellowing of the skin or eyes, or pain that does not settle needs urgent assessment through NHS 111 or A&E.
Raised bilirubin, whose sign is jaundice, is listed separately as uncommon.

Why weight loss causes gallstones

The gallbladder stores bile, a fluid the liver makes to digest fat. Bile contains cholesterol, and when the proportion of cholesterol rises, it can crystallise into stones. During rapid weight loss the liver releases extra cholesterol into bile as body fat is broken down. At the same time, eating less, and eating less fat in particular, means the gallbladder empties less often, so bile sits and concentrates. Both effects favour stone formation. This is well documented after very low calorie diets and bariatric surgery, and the same pattern appears in the semaglutide trials.

There is some evidence that GLP-1 medicines also directly reduce gallbladder emptying, which would add a small drug-specific effect on top of the weight loss effect. Either way, the practical points are the same.

Symptoms and what they mean

Pattern	Likely meaning	Route
Sudden severe pain under the right ribs or centre of the upper stomach, often an hour or so after a fatty meal, easing within a few hours	Biliary colic: a stone temporarily blocking the gallbladder outlet	Same-day GP or NHS 111 for assessment and a scan
The same pain but persisting for more than five hours, with fever or shivering, tenderness under the ribs	Possible cholecystitis: inflamed, infected gallbladder	NHS 111 now, or A&E
Yellowing of skin or whites of the eyes, dark urine, pale stools, itching	A stone blocking the bile duct, or raised bilirubin	Same-day assessment through NHS 111
Severe persistent pain in the upper stomach spreading to the back, with vomiting	Possible pancreatitis, which gallstones can trigger	Stop Wegovy and get urgent help; see the pancreatitis guide

None of these can be told apart reliably at home, and this page cannot diagnose you. Severe upper abdominal pain of any kind on Wegovy is a reason to get assessed rather than wait.

Reducing the risk

Do not add a crash diet on top. The medicine already produces rapid loss; extreme restriction makes gallstones more likely, not less. Aim for steady loss with regular meals.
Keep some fat in the diet. A small amount of healthy fat at meals prompts the gallbladder to empty. Avoiding fat entirely can backfire.
Do not skip meals for long stretches. Regular small meals keep bile moving.
Fibre and fluids. Both are associated with lower gallstone risk and help with the constipation that is also common on the medicine.
Tell your prescriber about any history of gallstones, gallbladder removal or gallbladder disease before starting.

If gallstones are found

Gallstones that cause no symptoms are usually left alone. Repeated painful attacks are typically treated by keyhole removal of the gallbladder, one of the most common operations in the UK, and people manage perfectly well without it. Whether Wegovy continues through diagnosis and treatment is a prescriber decision; the leaflet asks you to tell your doctor about any planned surgery under anaesthetic because of the effect on stomach emptying.

Frequently asked questions

Does Wegovy cause gallstones?

Gallstones are a common listed side effect, reported in roughly 1.6% of people on semaglutide in weight management trials against 0.7% on placebo. The main mechanism is rapid weight loss, which raises gallstone risk however it is achieved.

What does gallstone pain feel like on Wegovy?

Typically sudden, severe pain under the right ribs or in the upper stomach, often after a fatty meal, lasting from one to a few hours. With fever, shivering or jaundice it may be an infected gallbladder or a blocked duct and needs urgent assessment.

Can I take Wegovy if I have had my gallbladder removed?

Having no gallbladder removes the gallstone risk. Tell your prescriber at the consultation. It is not a reason on its own to avoid the medicine.

Should I avoid all fat to prevent gallstones?

No. A small amount of fat at meals makes the gallbladder empty, which reduces stone formation. Extreme low fat diets during rapid weight loss increase the risk.

Is jaundice a Wegovy side effect?

Raised bilirubin, whose visible sign is yellowing of the skin or eyes, is listed as uncommon. It can also mean a gallstone blocking the bile duct. Either way it needs same-day assessment.

Sources and about this guide

Written by Nick Johnson, founder of Medstack Ltd and Independent Prescription Pricing Analyst. Checked 20 October 2026 against the June 2026 leaflet. Next review 5 December 2026. iGovy is an independent price comparison site. It does not sell, prescribe or dispense medicines, and this page is general information, not medical advice. No clinician has reviewed it yet. A named reviewer will be added when appointed.

How this guide was checked: every frequency statement was compared line by line with section 4 of the Wegovy FlexTouch patient leaflet revised June 2026 and sections 4.4 and 4.8 of the Summary of Product Characteristics on the eMC. Trial figures are quoted from the SmPC or the published STEP papers, never from pharmacy marketing, and NHS pages are used for the description of gallstones and cholecystitis. The page is re-checked whenever the eMC record changes or the MHRA issues a Drug Safety Update, and at least every three months.

Funding and independence: iGovy earns referral commission when readers use pharmacy discount codes on its price pages. No pharmacy or manufacturer paid for, saw or influenced this guide, and health content is not affected by commercial arrangements. Full policy on the editorial policy page. Corrections via the contact page.